ONE-WAYOngoing theme · still written in the latest filings
Research and development of treatments for brain and neuropsychiatric diseases using TLG-005
A theme focused on application research and partnership negotiations toward commercialization for TLG-005, which uses violet light technology, in brain and neuropsychiatric diseases such as depression, dementia and Parkinson’s disease.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2022 →Still being written about.
Directionhelps1 helps · 0 hurts · 0 flat